Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Antidiabetics Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Antidiabetics Market: Antidiabetics Product Outlook Insights
4.1. Global Antidiabetics Product Outlook Historic Market Data & Future Forecasts, 2016-2027
4.2. Alpha-glucosidase inhibitors
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Biguanides
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Sulphonylureas
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. GLP-1 agonist
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Meglitinides
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.7. DPP-4 inhibitors
4.7.1. Historic Market Data & Future Forecasts, 2016-2027
4.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.8. SGLT – 2
4.8.1. Historic Market Data & Future Forecasts, 2016-2027
4.8.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.9. Thiazolidinediones
4.9.1. Historic Market Data & Future Forecasts, 2016-2027
4.9.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Antidiabetics Market: Insulin Product Outlook Insights
5.1. Global Insulin Product Outlook Historic Market Data & Future Forecasts, 2016-2027
5.2. Rapid-acting
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Long-acting
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Premixed
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5. Premixed analog
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.6. Short-acting
5.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.7. Intermediate-acting
5.7.1. Historic Market Data & Future Forecasts, 2016-2027
5.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Antidiabetics Market: Regional Insights
6.1. Global Antidiabetics Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
Chapter 7. Company Profiles
7.1. Pfizer
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Halozyme Therapeutics
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Bristol-Myers Squibb
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Novo Nordisk
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Merck & Co. Inc.
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Oramed Pharmaceuticals Inc.
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Eli Lilly
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. Takeda Pharmaceuticals
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. Sanofi Aventis
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
List of Tables
Table 1 Antidiabetics Market Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 2 Antidiabetics Market Data & Future Forecasts, By Region, 2016-2027 (USD Million)
Table 3 Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 4 Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 5 Alpha-glucosidase inhibitors Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 6 Biguanides Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 7 Sulphonylureas Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 8 GLP-1 agonist Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 9 Meglitinides Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 10 DPP-4 inhibitors Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 11 SGLT – 2 Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 12 Thiazolidinediones Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 13 Rapid-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 14 Long-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 15 Premixed Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 16 Premixed analog Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 17 Short-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 18 Intermediate-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 19 North America Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 20 North America Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 21 North America Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 22 U.S. Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 23 U.S. Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 24 U.S. Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 25 Canada Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 26 Canada Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 27 Canada Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 28 Europe Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 29 Europe Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 30 Europe Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 31 U.K. Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 32 U.K Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 33 U.K Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 34 Germany Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 35 Germany Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 36 Germany Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 37 France Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 38 France Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 39 France Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 40 Asia Pacific Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 41 Asia Pacific Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 42 Asia Pacific Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 43 China Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 44 China Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 45 China Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 46 India Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 47 India Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 48 India Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 49 Japan Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 50 Japan Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 51 Japan Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 52 South Korea Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 53 South Korea Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 54 South Korea Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 55 Latin America Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 56 Latin America Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 57 Latin America Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 58 Brazil Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 59 Brazil Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 60 Brazil Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 61 Mexico Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 62 Mexico Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 63 Mexico Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 64 Middle East & Africa Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 65 Middle East & Africa Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 66 Middle East & Africa Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 67 UAE Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 68 UAE Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 69 UAE Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 70 South Africa Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 71 South Africa Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 72 South Africa Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Antidiabetics Market, by 2016-2027 (USD Million)
Fig.3 Antidiabetics Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Antidiabetics Market Driver Anlaysis
Fig.6 Antidiabetics Market Restraint Analysis
Fig.7 Antidiabetics Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Antidiabetics Market
Fig.10 Company Market Share Analysis, 2019